Frontiers in Oncology | Molecular and Cellular Oncology

Review

Published on 01 Jul 2025

Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance

in Molecular and Cellular Oncology

Minhan Jin
Yuhui Wang
Mingze Song
Wenfei Guo
Shirong Li
Zeqing Pu

Frontiers in Oncology

doi 10.3389/fonc.2025.1566598

385 views

Systematic Review

Published on 01 Jul 2025

Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies

in Molecular and Cellular Oncology

Huyen Thuc Tran Luong
Sofie Vercammen
Ario de Marco
Hilde de Rooster
Antonio Cosma

Frontiers in Oncology

doi 10.3389/fonc.2025.1623327

372 views

Correction

Accepted on 30 Jun 2025

Correction: Identification of hub genes within the CCL18 signaling pathway in hepatocellular carcinoma through bioinformatics analysis

in Molecular and Cellular Oncology

Jinlei Mao
Yuhang Tao
Keke Wang
Hanru Sun
Manqi Zhang
Liang Jin
Yi Pan

Frontiers in Oncology

doi 10.3389/fonc.2025.1649612

155 views

Original Research

Accepted on 30 Jun 2025

The construction and evaluation of a prognostic risk score model for HCC based on MPT-related LncRNAs

in Molecular and Cellular Oncology

Zerun Lin
Jianda Yu
Zhijian Chen
Jingyi Chen
Xiaobin Chi
Honghuan Lin
Yongbiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1590094

Original Research

Accepted on 30 Jun 2025

A study on the clinical value of prophylactic contralateral central lymph node dissection in patients with cT1-T2N1b unilateral papillary thyroid cancer

in Molecular and Cellular Oncology

Suqiong Lin
Rongliang Qiu
Yujuan Tang
Xiaoquan Hong
Qiangbin Ding
Ke Li
Ende Lin
Penghao Kuang
Jinbo Fu
Guoyang Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1629656

Review

Accepted on 30 Jun 2025

YBX1: An RNA/DNA-binding protein that affects disease progression

in Molecular and Cellular Oncology

Xifeng Zheng
Feng Zeng
Yan Lei
Li Yanling
Jun Deng
Gengqiu Luo
Qian He
Yanhong Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1635209

Original Research

Published on 30 Jun 2025

Prevalence of human papillomavirus genotypes in Latvia among women participating in cervical cancer screening

in Molecular and Cellular Oncology

Anna Stasulane
Justine Grundmane
Kristiana Sulte
Janis Stasulans
Solvita Cernavska
Laura Smite

Frontiers in Oncology

doi 10.3389/fonc.2025.1584677

342 views

Systematic Review

Published on 30 Jun 2025

Bibliometric analysis combined with visualization on universal trends and hot topics of LOX family in human diseases: 1995 to 2025

in Molecular and Cellular Oncology

Tingting Yang
Heng Li
Wenxuan Zhou
Ning Zhang
Zhenyu Tian
Heming Wang
Yuyan Feng
Yunguang Chen
Zhen Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1601261

235 views

Original Research

Accepted on 26 Jun 2025

To Explore the Potential of LOXL2 as a Biomarker in Glioma and Construct a Genomic Integrated Clinical Prognostic Model

in Molecular and Cellular Oncology

Hongjuan Wang
Qunli Li
Xiangtao Zheng
Weibiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1602475

115 views

Review

Published on 26 Jun 2025

Decoding estrogen receptor and GPER biology: structural insights and therapeutic advances in ERα−positive breast cancer

in Molecular and Cellular Oncology

Taniya Saha
Kiven Erique Lukong

Frontiers in Oncology

doi 10.3389/fonc.2025.1513225

313 views

Review

Published on 26 Jun 2025

The role of DNA methylation and demethylation in bladder cancer: a focus on therapeutic strategies

in Molecular and Cellular Oncology

Wiktoria Strasenburg
Jędrzej Borowczak
Daria Piątkowska
Jakub Jóźwicki
Dariusz Grzanka

Frontiers in Oncology

doi 10.3389/fonc.2025.1567242

338 views

Original Research

Accepted on 25 Jun 2025

Significance of FXa and its receptor PAR2 for the growth of colon cancer cells in vitro and in vivo

in Molecular and Cellular Oncology

Ulrike Meyer
Vincent Rönnpagel
Sophie Grammbauer
Mirjam von Lucadou
Ursula Rauch-Kröhnert
Edzard Schwedhelm
Frank Dombrowski
Christoph Ritter
Bernhard H. Rauch

Frontiers in Oncology

doi 10.3389/fonc.2025.1631350

Original Research

Published on 25 Jun 2025

Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants

in Molecular and Cellular Oncology

Chenye Tang
Xiao Guo
Qian Zou
Xinghao Wang
Jian Sheng
Dan Shen
Chun Sun
Shuo Li
Ruilin Shen

Frontiers in Oncology

doi 10.3389/fonc.2025.1604169

419 views

Original Research

Published on 25 Jun 2025

RBP7 knockdown inhibits proliferation of human hepatocellular carcinoma and activates the p38 MAPK pathway

in Molecular and Cellular Oncology

Jinhai Li
Huawei Zhai
Fujing Cai
Xian Zhang
Yu Zhou
Shuqun Li
Huachun Song
Haifeng Zhang
Guangzheng Sun
Minghui Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1592616

261 views

Original Research

Published on 24 Jun 2025

CHMP6 as a novel prognostic biomarker in bladder cancer: insights from a comprehensive cell death-related gene risk model

in Molecular and Cellular Oncology

Wei Ning
Yan-Ru Yang
Chen-Xu Wu
Yue Hou
Zhi-Wei Liu
Chang-Bin Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1564826

418 views

Original Research

Published on 24 Jun 2025

p53 enhances elesclomol-Cu-induced cuproptosis in hepatocellular carcinoma via FDXR-mediated FDX1 upregulation

in Molecular and Cellular Oncology

Xiao Liu
Honglin Qu
Jingmin Li
Xuhong Sun
Zhenlin Wang
Dong Wang
Xianyong Bai
Xiaoyan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1584811

423 views